USPTO serial 79387327
THERMOSENSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2024
- Examiner
- BELL, JUSTIN T
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with THERMOSENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eunyoung Lee
Eunyoung Lee Monami Law Group PLLC100 LARA ST. UNIT 508302, 16, Nonhyeon-ro 75-gilMANASSAS PARK, VA 20111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; chemical preparations for scientific or laboratory purposes; reagents for scientific purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparations, for use in cell cultures other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; reagents for medical research | ACTIVE | — |
| 005 | Drug delivery agents in the form of local injection, transdermal, topical, intradermal dosage, spray, implant that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; bone cement for surgical and orthopaedic purposes; topical gels for medical and therapeutic purposes, namely, local hydrogel or sprayable hydrogel improved patient compliance; biological tissue cultures for medical purposes; biological preparations for medical purposes, namely, for the treatment of wound healing, bone defect, spinal cord injury, cell therapy; embedding material in the nature of thermosensitive hydrogel containing polyphosphazene for dental purposes, namely, alveolar bone therapy; materials for tooth fillings; preparations to facilitate teething being teething prophylactics; preparations to develop teething being teething prophylactics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nexgel Biotech Co., Ltd.
- Other trademarks owned by Nexgel Biotech Co., Ltd.
- Other trademarks owned by Nexgel Biotech Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named THERMOSENSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 10, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 10, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 24, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 7, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 7, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 3, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 1, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 15, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 12, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 11, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |